Dermal Filler

HA filler results may last approximately six months to one year or longer. Longevity depends on the product, treatment area, amount injected, facial movement and individual metabolism. Results are temporary and vary between patients.

The goal is to create a balanced result that works with your existing facial anatomy. Product selection, placement and amount all affect the outcome. Conservative treatment and staged reassessment may be recommended when a subtle result is preferred.

No. Hyaluronidase may be used to dissolve certain hyaluronic acid fillers when clinically appropriate, but it does not dissolve every filler or injectable product. Radiesse®, Sculptra® and Belkyra® should not be described as reversible with hyaluronidase.

Swelling, redness, tenderness and bruising are common following injection. Many patients continue normal daily activities, but visible swelling or bruising can persist for several days and occasionally longer. Final assessment should wait until the initial swelling has settled.

Reported reactions include pain, swelling, redness, bruising, nodules, infection, allergic reactions, discoloration and improper product placement. Some reactions can persist and may require additional treatment.

Rare but serious vascular complications can occur if filler enters or compresses a blood vessel. These may lead to tissue damage, vision impairment, blindness or stroke. Seek immediate medical attention for unusual pain, skin blanching or discoloration, vision changes or sudden neurological symptoms.

HA fillers add support or volume using hyaluronic acid gel and usually produce an immediate visible change. Radiesse® contains calcium hydroxylapatite, while Sculptra® contains poly-L-lactic acid and produces more gradual biostimulatory changes. The products have different indications, treatment schedules, risks and reversibility, so they should be selected through an individual consultation.